Gender-Specific Medicine in the European Society of Cardiology Guidelines from 2018 to 2023: Where Are We Going?
Open Access
- 10 July 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4026
Abstract
Background/Objectives: Evidence-based medicine (EBM) shapes most clinical guidelines. Although the advent of EBM marked a significant advancement, failure to include sex differences in the study design and analysis of most trials leads to an under-representation of gender-specific medicine (GM) in EBM-directed guidelines. In this review, we evaluated how the topic of GM was developed in the guidelines produced by the European Society of Cardiology (ESC) from 2018 to 2023. Methods: Two independent reviewers evaluated 24 ESC guidelines. Significant mentions of GM were counted and divided between epidemiology, diagnosis, and therapeutics. The qualitative and semi-quantitative analysis of information relating to GM was performed. Data on the number of citations of papers with a title concerning GM and the prevalence and role of women in guidelines’ authorship were also analyzed. Results: Less than 50% of guidelines had a section dedicated to GM. Only nine guidelines were led by a woman, and 144/567 authors were female. In the most recent guidelines and in those with at least 30% of female authors, there was an increased mention of GM. On average, guidelines had four significant mentions of GM regarding epidemiology, two regarding diagnosis, and one regarding therapy. Articles with titles concerning GM made up, on average, 1.5% of the total number of citations. Conclusions: Although sex differences play a significant role in most clinical scenarios, ESC guidelines still do not sufficiently account for this. The problem does not seem to solely lie in the guidelines, but in the lack of attention to GM in research needed for their preparation.Keywords
This publication has 42 references indexed in Scilit:
- Hypertension: Are Current Guidelines Inclusive of Sex and Gender?Journal of Women's Health, 2022
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal, 2022
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESCRevista Española de Cardiología (English Edition), 2022
- The Proportion of Women Authors and the Inclusion of Sex and Gender Content Among the American College of Cardiology Clinical Practice Guidelines, 2008–2018Journal of Women's Health, 2021
- The ESC Clinical Practice Guidelines for the Management of Adult Congenital Heart Disease 2020European Heart Journal, 2020
- Sex differences in cardiovascular actions of the renin–angiotensin systemClinical Autonomic Research, 2020
- 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular diseaseEuropean Heart Journal, 2020
- Sex-Specific Considerations in Guidelines Generation and ApplicationCanadian Journal of Cardiology, 2019
- NIH Policy on the Inclusion of Women and Minorities as Subjects in Clinical Research2002
- The Yentl SyndromeNew England Journal of Medicine, 1991